Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
201113.8k citationsMartin N. Rossor et al.profile →
Current Concepts in Mild Cognitive Impairment
20013.8k citationsMartin N. Rossor et al.profile →
Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria
20073.2k citationsMartin N. Rossor et al.profile →
Early-onset Alzheimer's disease caused by mutations at codon 717 of the β-amyloid precursor protein gene
1991913 citationsHenry Houlden, Martin N. Rossor et al.profile →
Potassium channel antibody‐associated encephalopathy: a potentially immunotherapy‐responsive form of limbic encephalitis
2004729 citationsJonathan M. Schott, Martin N. Rossor et al.profile →
A Longitudinal Study of Brain Volume Changes in Normal Aging Using Serial Registered Magnetic Resonance Imaging
2003675 citationsRachael I. Scahill, Jennifer L. Whitwell et al.profile →
Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia
Mapping the evolution of regional atrophy in Alzheimer's disease: Unbiased analysis of fluid-registered serial MRI
2002566 citationsRachael I. Scahill, Jonathan M. Schott et al.profile →
Patterns of temporal lobe atrophy in semantic dementia and Alzheimer's disease
2001542 citationsDennis Chan, Nick C. Fox et al.profile →
11C-PiB PET assessment of change in fibrillar amyloid-β load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study
2010536 citationsJuha O. Rinne, David J. Brooks et al.profile →
Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples
1999513 citationsMartin N. Rossor, Safa Al‐Sarraj et al.profile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
Countries citing papers authored by Martin N. Rossor
Since
Specialization
Citations
This map shows the geographic impact of Martin N. Rossor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin N. Rossor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin N. Rossor more than expected).
Fields of papers citing papers by Martin N. Rossor
This network shows the impact of papers produced by Martin N. Rossor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin N. Rossor. The network helps show where Martin N. Rossor may publish in the future.
Co-authorship network of co-authors of Martin N. Rossor
This figure shows the co-authorship network connecting the top 25 collaborators of Martin N. Rossor.
A scholar is included among the top collaborators of Martin N. Rossor based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Martin N. Rossor. Martin N. Rossor is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Schott, Jonathan M., Lisa Cipolotti, Rachael I. Scahill, et al.. (2004). Presymptomatic focal atrophy precedes speech production impairment in familial frontotemporal lobar degeneration. UCL Discovery (University College London).1 indexed citations
10.
Hall, Michael E., et al.. (2002). Early cognitive decline in Creutzfeldt-Jakob disease occurring in recipients of pituitary-derived human growth hormone. UCL Discovery (University College London).1 indexed citations
Rossor, Martin N., Elizabeth K. Warrington, & Lisa Cipolotti. (1995). The isolation of calculation skills. Journal of Neurology. 242(2). 78–81.76 indexed citations
16.
Rossor, Martin N., et al.. (1993). ALZHEIMERS-DISEASE FAMILIES WITH AMYLOID PRECURSOR PROTEIN MUTATIONS. UCL Discovery (University College London).2 indexed citations
17.
Hardy, John, Henry Houlden, John Collinge, et al.. (1993). APOLIPOPROTEIN-E GENOTYPE AND ALZHEIMERS-DISEASE. UCL Discovery (University College London).246 indexed citations
18.
Hope, Robert, et al.. (1989). RECOMMENDED MINIMUM DATA TO BE COLLECTED IN RESEARCH STUDIES ON ALZHEIMERS-DISEASE. UCL Discovery (University College London).8 indexed citations
Emson, P.C., D. Dawbarn, Martin N. Rossor, et al.. (1985). CHOLECYSTOKININ CONTENT IN THE BASAL GANGLIA IN HUNTINGTONS-DISEASE - THE EXPRESSION OF CHOLECYSTOKININ IMMUNOREACTIVITY IN STRIATAL GRAFTS TO IBOTENIC ACID-LESIONED RAT STRIATUM. UCL Discovery (University College London).1 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.